Holen Sie sich die Stockscreener-App
6.43
2.58%
-0.17
Handel nachbörslich:
6.47
0.04
+0.62%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against LifeMD, Inc. (LFMD) And Encourages Stockholders to Reach Out - ACCESS Newswire
What is the earnings history of LifeMD Inc.Chart Signals & Weekly Top Gainers Alerts - sundaytimes.kr
Insider Spends US$501k Buying More Shares In LifeMD - 富途牛牛
LifeMD, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating LifeMD, Inc. (LFMD) And Encourages Stockholders to Connect - ACCESS Newswire
Securities Litigation and Shareholder Turmoil at LifeMD: A Case Study in Corporate Transparency and Market Reactions - AInvest
Investigation into Potential Securities Claims against LifeMD, Inc. - AInvest
LFMD Investor News: Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action InvestigationLFMD - MarketScreener
LifeMD Investors Encouraged to Inquire About Securities Class Action Investigation - AInvest
Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation – LFMD - The Joplin Globe
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17 Per Common Share for August 2025 - The Globe and Mail
Is LifeMD Inc. a top pick in the sectorBuyback Announcements Stock Watch - thegnnews.com
HC Wainwright Lowers LifeMD Price Target to $13.00, Maintains "Buy" Rating - AInvest
LifeMD price target lowered to $13 from $14 at H.C. Wainwright - TipRanks
LifeMD, Inc. (NASDAQ:LFMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Positive Sentiment Still Eludes LifeMD, Inc. (NASDAQ:LFMD) Following 46% Share Price Slump - simplywall.st
LifeMD Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
LifeMD (LFMD) Target Price Lowered by HC Wainwright & Co. to $13 - GuruFocus
LifeMD’s Strong Growth Potential and Strategic Diversification Support Buy Rating Despite Revenue Guidance Adjustment - TipRanks
LifeMD: HC Wainwright lowers Buy rating to $13 from $14. - AInvest
Tidewater Inc.’s Financial Stability at Risk: How Debt Covenants Threaten Liquidity and Growth - The Globe and Mail
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates - MSN
LifeMD Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
LifeMD Expects Q3 Adjusted EBITDA of $6M-$7M, Revenue Growth at 19.5%, and Mixed Financial Health - AInvest
LifeMD Reports Q2 2025 Revenue Growth of 23% to $62.2mln, Adjusted EBITDA Surges 223% to $7.1mln. - AInvest
LifeMD Stock Plummets 40%. Why Weight Loss Isn't Just A Gimme. - Investor's Business Daily
LifeMD shares drop 44.55% intraday despite Q2 revenue growth and debt repayment. - AInvest
LifeMD stock price target lowered to $12 at KeyBanc on elevated costs - Investing.com Nigeria
LifeMD price target lowered to $14 from $18 at Lake Street - TipRanks
LifeMD Misses Estimates, But Keeps Growing And Diversifying - Finimize
LifeMD Down Nearly 46%, on Track for Record Percent Decrease -- Data Talk - 富途牛牛
Lake Street Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $14 - 富途牛牛
LifeMD Plummets 44%: A Telehealth Titan's Turbulent Turnaround? - AInvest
LifeMD (LFMD) Analyst Lowers Price Target but Maintains Overweig - GuruFocus
LifeMD Plummets 40.96%: Earnings Shock and Sector Headwinds Spark Investor Exodus - AInvest
LifeMD slumps after firm cuts 2025 revenue forecast - TradingView
TR | OpenAI4o Maintains LifeMD(LFMD.US) With Hold Rating, Cuts Target Price to $12.5 - 富途牛牛
KeyBanc Adjusts LifeMD (LFMD) Price Target Amid Business Strateg - GuruFocus
LifeMD 2025 Q2 Earnings Significant Loss Reduction - AInvest
LifeMD (LFMD) Q2 Revenue Rises 23% - The Globe and Mail
LifeMD, Inc. Reports Strong Q2 2025 Growth - TipRanks
LifeMD’s CEO Makes a Bold Move with Significant Stock Sale - TipRanks
LifeMD's Q2 2025 Earnings Call: Navigating Contradictions in Insurance Strategy and Customer Acquisition Costs - AInvest
LifeMD (LFMD) Revenues and Earnings Miss Expectations - GuruFocus
LifeMD (LFMD) Updates Financial Guidance Amid Revenue Growth - GuruFocus
Earnings call transcript: LifeMD Q2 2025 misses expectations, stock dips - Investing.com
LifeMD CEO Schreiber sells $249,690 in shares By Investing.com - Investing.com Nigeria
LifeMD CEO Schreiber sells $249,690 in shares - Investing.com
LifeMD August 2025 slides: Virtual healthcare platform targets $255M in 2025 revenue - Investing.com Canada
LifeMD August 2025 slides: Virtual healthcare platform targets $255M in 2025 revenue By Investing.com - Investing.com South Africa
LifeMD reports Q2 EPS (6c) vs. (19c) last year - TipRanks
LifeMD shares plunge as Q2 results miss, guidance cut By Investing.com - Investing.com Canada
LifeMD shares plunge as Q2 results miss, guidance cut - Investing.com
LifeMD cuts FY25 revenue view to $250M-$255M from $268M-$275M - TipRanks
LifeMD Q2 revenue rises but misses expectations - MarketScreener
LifeMD earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
2.70%
7.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):